These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29053105)

  • 81. Calculation of the spatial variation of relative biological effectiveness in a therapeutic proton field for eye treatment.
    Paganetti H
    Phys Med Biol; 1998 Aug; 43(8):2147-57. PubMed ID: 9725595
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Off-axis dose equivalent due to secondary neutrons from uniform scanning proton beams during proton radiotherapy.
    Islam MR; Collums TL; Zheng Y; Monson J; Benton ER
    Phys Med Biol; 2013 Nov; 58(22):8235-51. PubMed ID: 24201018
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Theoretical dosimetric evaluation of carbon and oxygen minibeam radiation therapy.
    González W; Peucelle C; Prezado Y
    Med Phys; 2017 May; 44(5):1921-1929. PubMed ID: 28236644
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluation of the dosimetric properties of a diode detector for small field proton radiosurgery.
    McAuley GA; Teran AV; Slater JD; Slater JM; Wroe AJ
    J Appl Clin Med Phys; 2015 Nov; 16(6):51-64. PubMed ID: 26699554
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Radiation quality correction factors for improved dosimetry in preclinical minibeam radiotherapy.
    Sotiropoulos M; Prezado Y
    Med Phys; 2022 Oct; 49(10):6716-6727. PubMed ID: 35904962
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Quantification of the uncertainties of a biological model and their impact on variable RBE proton treatment plan optimization.
    Resch AF; Landry G; Kamp F; Cabal G; Belka C; Wilkens JJ; Parodi K; Dedes G
    Phys Med; 2017 Apr; 36():91-102. PubMed ID: 28410691
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay.
    Calugaru V; Nauraye C; Noël G; Giocanti N; Favaudon V; Mégnin-Chanet F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1136-43. PubMed ID: 21075549
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Systematic out-of-field secondary neutron spectrometry and dosimetry in pencil beam scanning proton therapy.
    Trinkl S; Mares V; Englbrecht FS; Wilkens JJ; Wielunski M; Parodi K; Rühm W; Hillbrand M
    Med Phys; 2017 May; 44(5):1912-1920. PubMed ID: 28294362
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dose Profile Modulation of Proton Minibeam for Clinical Application.
    Kim M; Hwang UJ; Park K; Kim D; Kim HS; Choi SH; Jeong JH; Shin D; Lee SB; Kim JY; Kim TH; Baek HJ; Kim H; Kim K; Kim SS; Lim YK
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740553
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Impact of uncertainties in range and RBE on small field proton therapy.
    Marteinsdottir M; Schuemann J; Paganetti H
    Phys Med Biol; 2019 Oct; 64(20):205005. PubMed ID: 31519016
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A novel methodology to assess linear energy transfer and relative biological effectiveness in proton therapy using pairs of differently doped thermoluminescent detectors.
    Parisi A; Chiriotti S; De Saint-Hubert M; Van Hoey O; Vandevoorde C; Beukes P; de Kock EA; Symons J; Camero JN; Slabbert J; Mégret P; Debrot E; Bolst D; Rosenfeld A; Vanhavere F
    Phys Med Biol; 2019 Apr; 64(8):085005. PubMed ID: 30650402
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Relative Biological Effectiveness Uncertainties and Implications for Beam Arrangements and Dose Constraints in Proton Therapy.
    Paganetti H; Giantsoudi D
    Semin Radiat Oncol; 2018 Jun; 28(3):256-263. PubMed ID: 29933885
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction.
    Choi C; Son A; Lee GH; Shin SW; Park S; Ahn SH; Chung Y; Yu JI; Park HC
    PLoS One; 2019; 14(6):e0218049. PubMed ID: 31194786
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using Chinese hamster V79 cells and the high-precision cell sorter assay.
    Wouters BG; Lam GK; Oelfke U; Gardey K; Durand RE; Skarsgard LD
    Radiat Res; 1996 Aug; 146(2):159-70. PubMed ID: 8693066
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Proton pencil minibeam irradiation of an in-vivo mouse ear model spares healthy tissue dependent on beam size.
    Sammer M; Zahnbrecher E; Dobiasch S; Girst S; Greubel C; Ilicic K; Reindl J; Schwarz B; Siebenwirth C; Walsh DWM; Combs SE; Dollinger G; Schmid TE
    PLoS One; 2019; 14(11):e0224873. PubMed ID: 31765436
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
    Titt U; Zheng Y; Vassiliev ON; Newhauser WD
    Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Measurement of stray radiation within a scanning proton therapy facility: EURADOS WG9 intercomparison exercise of active dosimetry systems.
    Farah J; Mares V; Romero-Expósito M; Trinkl S; Domingo C; Dufek V; Klodowska M; Kubancak J; Knežević Ž; Liszka M; Majer M; Miljanić S; Ploc O; Schinner K; Stolarczyk L; Trompier F; Wielunski M; Olko P; Harrison RM
    Med Phys; 2015 May; 42(5):2572-84. PubMed ID: 25979049
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Establishment of a New Three-Dimensional Dose Evaluation Method Considering Variable Relative Biological Effectiveness and Dose Fractionation in Proton Therapy Combined with High-Dose-Rate Brachytherapy.
    Kobayashi D; Isobe T; Takada K; Mori Y; Takei H; Kumada H; Kamizawa S; Tomita T; Sato E; Yokota H; Sakae T
    J Med Phys; 2019; 44(4):270-275. PubMed ID: 31908386
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.